These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Molecular testing for infectious diseases should be done in the clinical microbiology laboratory. Mosammaparast N; McAdam AJ; Nolte FS J Clin Microbiol; 2012 Jun; 50(6):1836-40. PubMed ID: 22422845 [TBL] [Abstract][Full Text] [Related]
6. Collaborative Antimicrobial Stewardship: Working with Microbiology. Palavecino EL; Williamson JC; Ohl CA Infect Dis Clin North Am; 2020 Mar; 34(1):51-65. PubMed ID: 31836331 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Stewardship: Opportunity for a Laboratory-Infectious Diseases Partnership. Patel R; Fang FC Clin Infect Dis; 2018 Aug; 67(5):799-801. PubMed ID: 29547995 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship. Morency-Potvin P; Schwartz DN; Weinstein RA Clin Microbiol Rev; 2017 Jan; 30(1):381-407. PubMed ID: 27974411 [TBL] [Abstract][Full Text] [Related]
9. Role of molecular diagnostics in the management of infectious disease emergencies. Krishna NK; Cunnion KM Med Clin North Am; 2012 Nov; 96(6):1067-78. PubMed ID: 23102477 [TBL] [Abstract][Full Text] [Related]
11. A challenge and an opportunity to improve patient management and public health surveillance for food-borne infections through culture-independent diagnostics. Atkinson R; Maguire H; Gerner-Smidt P J Clin Microbiol; 2013 Aug; 51(8):2479-82. PubMed ID: 23515538 [No Abstract] [Full Text] [Related]
12. Diagnostic stewardship in infectious diseases: a continuum of antimicrobial stewardship in the fight against antimicrobial resistance. Zakhour J; Haddad SF; Kerbage A; Wertheim H; Tattevin P; Voss A; Ünal S; Ouedraogo AS; Kanj SS; Int J Antimicrob Agents; 2023 Jul; 62(1):106816. PubMed ID: 37061101 [TBL] [Abstract][Full Text] [Related]
13. Molecular diagnostics in infectious diseases and public health microbiology: cottage industry to postgenomics. Gilbert GL Trends Mol Med; 2002 Jun; 8(6):280-7. PubMed ID: 12067614 [TBL] [Abstract][Full Text] [Related]
14. Molecular methods and platforms for infectious diseases testing a review of FDA-approved and cleared assays. Emmadi R; Boonyaratanakornkit JB; Selvarangan R; Shyamala V; Zimmer BL; Williams L; Bryant B; Schutzbank T; Schoonmaker MM; Amos Wilson JA; Hall L; Pancholi P; Bernard K J Mol Diagn; 2011 Nov; 13(6):583-604. PubMed ID: 21871973 [TBL] [Abstract][Full Text] [Related]
15. Who to Test, When, and for What: Why Diagnostic Stewardship in Infectious Diseases Matters. Morjaria S; Chapin KC J Mol Diagn; 2020 Sep; 22(9):1109-1113. PubMed ID: 32623114 [TBL] [Abstract][Full Text] [Related]
16. Point-of-Care Testing for Infectious Diseases: Past, Present, and Future. Kozel TR; Burnham-Marusich AR J Clin Microbiol; 2017 Aug; 55(8):2313-2320. PubMed ID: 28539345 [TBL] [Abstract][Full Text] [Related]
17. Implementation of infectious diseases rapid molecular diagnostic tests and antimicrobial stewardship program involvement in acute-care hospitals. Kondo M; Simon MS; Westblade LF; Jenkins SG; Babady NE; Loo AS; Calfee DP; Infect Control Hosp Epidemiol; 2021 May; 42(5):609-611. PubMed ID: 33059776 [TBL] [Abstract][Full Text] [Related]
18. Advances in addressing technical challenges of point-of-care diagnostics in resource-limited settings. Wang S; Lifson MA; Inci F; Liang LG; Sheng YF; Demirci U Expert Rev Mol Diagn; 2016; 16(4):449-59. PubMed ID: 26777725 [TBL] [Abstract][Full Text] [Related]
19. Implications of new technology for infectious diseases practice. Baron EJ Clin Infect Dis; 2006 Nov; 43(10):1318-23. PubMed ID: 17051500 [TBL] [Abstract][Full Text] [Related]
20. Use, location, and timeliness of clinical microbiology testing in Georgia for select infectious diseases. Brzozowski AK; Silk BJ; Berkelman RL; Loveys DA; Caliendo AM J Public Health Manag Pract; 2012; 18(4):E4-E10. PubMed ID: 22635201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]